Zhejiang Shapuaisi Pharmaceutical Co Ltd
Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. engages in the research and development, production, and sale of pharmaceutical products. The company provides its products to ophthalmology, antimicrobials, gynecology, and other classes. It offers its products in injections, oral solutions, eye drops, large-volume injections, oral solutions, tablets, granules, and other dosage forms. Zhejiang Shapuaisi… Read more
Zhejiang Shapuaisi Pharmaceutical Co Ltd (603168) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.005x
Based on the latest financial reports, Zhejiang Shapuaisi Pharmaceutical Co Ltd (603168) has a cash flow conversion efficiency ratio of 0.005x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥8.57 Million) by net assets (CN¥1.62 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Zhejiang Shapuaisi Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2008–2024)
This chart illustrates how Zhejiang Shapuaisi Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Zhejiang Shapuaisi Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Zhejiang Shapuaisi Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Gansu Guofang Gongmao(Grp)
SHG:601086
|
0.031x |
|
Entravision Communications
NYSE:EVC
|
0.102x |
|
Bang & Olufsen a/s
PINK:BGOUF
|
0.041x |
|
Guangxi Bossco Environmental Protection Technology Co Ltd
SHE:300422
|
-0.065x |
|
Profit Cultural & Creative Group Co Ltd
SHE:300640
|
-0.018x |
|
METALS EXPLOR. LS 00001
F:MJ4
|
N/A |
|
Protalix Biotherapeutics Inc
NYSE MKT:PLX
|
-0.071x |
|
Freegold Ventures Limited
OTCQX:FGOVF
|
0.000x |
Annual Cash Flow Conversion Efficiency for Zhejiang Shapuaisi Pharmaceutical Co Ltd (2008–2024)
The table below shows the annual cash flow conversion efficiency of Zhejiang Shapuaisi Pharmaceutical Co Ltd from 2008 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥1.59 Billion | CN¥25.67 Million | 0.016x | -32.69% |
| 2023-12-31 | CN¥1.73 Billion | CN¥41.49 Million | 0.024x | -64.41% |
| 2022-12-31 | CN¥1.72 Billion | CN¥115.72 Million | 0.067x | -9.54% |
| 2021-12-31 | CN¥1.35 Billion | CN¥100.78 Million | 0.075x | +120.75% |
| 2020-12-31 | CN¥1.31 Billion | CN¥44.09 Million | 0.034x | -15.48% |
| 2019-12-31 | CN¥1.49 Billion | CN¥59.47 Million | 0.040x | -41.06% |
| 2018-12-31 | CN¥1.48 Billion | CN¥100.37 Million | 0.068x | +146.44% |
| 2017-12-31 | CN¥1.66 Billion | CN¥45.57 Million | 0.027x | -85.11% |
| 2016-12-31 | CN¥1.59 Billion | CN¥294.33 Million | 0.185x | +44.05% |
| 2015-12-31 | CN¥891.62 Million | CN¥114.27 Million | 0.128x | -33.93% |
| 2014-12-31 | CN¥762.90 Million | CN¥147.99 Million | 0.194x | -41.85% |
| 2013-12-31 | CN¥353.31 Million | CN¥117.86 Million | 0.334x | +35.99% |
| 2012-12-31 | CN¥274.21 Million | CN¥67.27 Million | 0.245x | +227.15% |
| 2011-12-31 | CN¥201.95 Million | CN¥15.14 Million | 0.075x | -35.10% |
| 2010-12-31 | CN¥152.04 Million | CN¥17.57 Million | 0.116x | -56.11% |
| 2009-12-31 | CN¥109.67 Million | CN¥28.87 Million | 0.263x | +120.01% |
| 2008-12-31 | CN¥93.58 Million | CN¥11.20 Million | 0.120x | -- |